TITLE

Dr. Reddy's completes acquisition of UCB brands

PUB. DATE
July 2015
SOURCE
FRPT- Chemical Snapshot;7/5/2015, p1
SOURCE TYPE
Industry Profile
DOC. TYPE
Article
ABSTRACT
The article reports on the acquisition of selected UCB pharmaceutical portfolio by Dr. Reddy's Laboratories in India, Sri Lanka and Maldive to increase presence in the areas of pediatrics, dermatology and neurology.
ACCESSION #
110316397

 

Related Articles

  • Dr. Reddy's to acquire select products of Belgian firm, UCB.  // FRPT- Chemical Snapshot;4/19/2015, p14 

    The article reports that Dr. Reddy's Laboratories will purchase some products of biopharmaceutical firm UCB in Maldives, Sri Lanka, Nepal and India in April 2015.

  • Reddy-ly establishing a European presence.  // Pharmaceutical Technology Europe;May2008, Vol. 20 Issue 5, p9 

    The article focuses on the significance of the two European acquisitions of Dr. Reddy's Laboratories Ltd. to its generic pipeline and research and development (R&D) infrastructure. The author claims that the acquisitions could result in cheaper medicines produced by the pharmaceutical company....

  • Dr Reddy's Laboratories--good show.  // Chemical Business;Jul98, Vol. 12 Issue 7, p116 

    Reports on the financial performance of the Dr. Reddy's Laboratories company in fiscal year 1997-98. Turnover growth of the formulations business; Formulations sales in India; Sales of the bulk drugs business.

  • Dr Reddy's to expand bulk drug activities.  // Chemical Business;Aug95, Vol. 9 Issue 1, p30 

    Reports that Indian company Dr. Reddy's Lab is contemplating expanding its activities in the fields of bulk drugs as also formulations. Set up of unit by company; Costs; Other expansion by company.

  • Five pronged strategy. Desai, Suresh Thakur // Chemical Business;Dec97, Vol. 11 Issue 5, p23 

    Reports on the five-pronged strategy for bulk actives by Hyderabad, India-based Dr. Reddy's Laboratories to sustain its profitability.

  • Dr. Reddy's seeks global patents for 4 products.  // Chemical Business;Jun95, Vol. 8 Issue 11, p64 

    Reports on Dr. Reddy's Laboratories' efforts to obtain world-wide patents for four of its products. Search for joint venture partners in Russia and China; Increased demand for cheap generic substitutes in the United States.

  • Dr. Reddy's Laboratories Inc.  // Pharmaceutical Technology;Dec2010 Supplement, p92 

    The article presents the corporate profile of Dr. Reddy's Laboratories Inc., located in Bridgewater, New Jersey, where it was established in 1984 and has 14,000 active employees.

  • Takeda Acquires LigoCyte Pharma.  // Contract Pharma;Nov/Dec2012, Vol. 14 Issue 9, p94 

    The article offers information related to pharmaceutical industry acquisition. It says that LigoCyte Pharmaceuticals Inc. will be acquired by Takeda Pharmaceutical Co. Ltd. as part of the company's expansion for its vaccine business. It mentions that Pfizer Inc. has entered an option and merger...

  • Dr Reddy's launches Sildenafil tablets.  // BioSpectrum;Dec2012, Vol. 10 Issue 12, p14 

    The article reports that Sildenafil tablets, a bioequivalent generic version of REVATIO (Sildenafil) tablets, has been launched by Dr. Reddy's Laboratories.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics